Alterity Therapeutics Limited ( ATHE) - Stock Earnings
ATHE Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2024Q4 | -4.5 million USD | 997881 USD |
| 2025Q2 | -3.3 million USD | 2.5 million USD |
| 2025Q4 | -6.3 million USD | — USD |
ATHE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -9.2 million USD | 2.6 million USD |
| 2024 | -12.8 million USD | 2.7 million USD |
| 2025 | -8.0 million USD | 3.6 million USD |
| 2026 Est. | — | — |
ATHE
Price: $3.12
52 week price:
Earnings Per Share: -0.96 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Australia
Volume: 8900
Market Capitalization: 58.4 million